Thanks @yaireinhorn 🔥
This sector needs results and not hype. Allogeneic (including iPSC) needs to elevate performance here. Autologous is NOT the future here imo
Thanks @yaireinhorn 🔥
This sector needs results and not hype. Allogeneic (including iPSC) needs to elevate performance here. Autologous is NOT the future here imo
Update to @WHO Essential Medicines List on cancer. PD-1/PD-L1 immune checkpoint inhibitors expanded beyond melanoma to cervical, non-small cell lung, & colorectal cancer. Cancer medicines expert report stresses need for refining dose, duration, biomarkers: cdn.who.int/media/docs/def…
Update to @WHO Essential Medicines List on cancer. PD-1/PD-L1 immune checkpoint inhibitors expanded beyond melanoma to cervical, non-small cell lung, & colorectal cancer. Cancer medicines expert report stresses need for refining dose, duration, biomarkers: cdn.who.int/media/docs/def…
Have you completed your case study submission for #AMPath25? Submissions are due TOMORROW, so make sure you’ve completed yours before the deadline!
amp25.amp.org/abstract-poste…
Researchers engineered an inhalable small extracellular vesicle (sEV) loaded with mesothelin-specific CAR mRNA (CARmRNA@aCD206 sEVs) to generate CAR-Ms in situ. bit.ly/4oUOKET
#MDPIPharmaceutics
Special Issue "3D Bioprinting: Current Advances and Future Directions in Drug Delivery" is open for submissions. 💊
Guest Editors: Dr. Hyun-Ouk Kim and Dr. Hyungseok Lee
Read more at: brnw.ch/21wVndS
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
Among patients with chronic coronary syndrome at high atherothrombotic risk who were receiving an oral anticoagulant, the addition of aspirin led to a higher risk of cardiovascular death,…
🧬 Webinar Alert: "Modifiable Genetic and Non-Genetic Risk Factors for Breast Cancer." Approved for 1.0 CMLE and AMA PRA Category 1. Explore germline genetic testing for risk assessment. Register👉 ow.ly/cycR50U3Ai2#molpath
Educational Strategies for Clinical Supervision of Artificial Intelligence Use
Use of artificial intelligence (AI) for the development of expert practice presents unprecedented opportunities but also poses risks, such as “deskilling,” “never-skilling,” and “mis-skilling.”…
Science domesticated wild plants.
Science bred higher yields.
Science decoded DNA.
Science built GMOs to feed billions.
Pseudoscience?
It spreads fear about the tools that made it all possible.
The Prehospital Phase of Acute Heart Failure Care: A Population-Based Cohort Study
HF is a high risk but under-recognized and undertreated cause of EMS attendance, associated with high rates of hospitalization and mortality
jacc.org/doi/10.1016/j.…
Eliminating barriers to #mentalhealth care for physicians is essential to prevent untreated conditions and suicides, improve well-being, and maintain high-quality patient care.
ja.ma/3UYC7dZ
Last call to apply for the ASH Clinical Research Training Institute Asia-Pacific (CRTI-APAC)! A great chance for early- to mid-career #Hematology faculty to join didactic sessions and mentoring! Apply now: ow.ly/hWzw50Wxknr#Hematology#ASHTrainee
Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement: With the contribution of the European Association of Preventive Cardiology (EAPC), the Association for Acute CardioVascular Care (ACVC), and the Heart Failure…
🚨New data release 🚨
Orforglipron demonstrates the highest weight loss achieved with an oral small molecule medication ever in its latest ATTAIN-1 phase 3 trial, announced today 👀
Once-daily orforglipron demonstrates 12.4% weight loss over 72 weeks in adults with obesity and…
Real-world effectiveness and safety of sodium-glucose co-transporter 2 inhibitors in chronic kidney disease
SGLT2i therapy might reduce adverse kidney outcomes in CKD patients, regardless of diabetic status, with a favorable safety profile
nature.com/articles/s4159…
🎙️ Highlight from #ICE_T2025
CancerNetwork (@CancerNetwrk) spoke with Dr. Nausheen Ahmed (@NausheenAhmedMD) at the inaugural National Immune Cell Effector Therapy (ICE-T) Conference.
💡 Focus: Making CAR T-cell therapy safer and more accessible for patients nationwide. See Full…
75 Followers 201 FollowingAssociate professor & Deputy head for education/Dpt. of Internal Medicine, Hematology and Oncology @FNBrno @muni_cz /chronic myeloid leukemia🩺🩸📊🧬
16K Followers 5K FollowingDeputy Chair of Lymphoma/Myeloma, Vice Chair MM Research @ MD Anderson; Translational researcher who hates myeloma. Tweets are my own. Retweets ≠ endorsements.
8K Followers 585 FollowingRevision aid for the FRCPath and RCPA haematology exams. We also do great haematology CPD for scientists, haematologists and pathologists🔬
93K Followers 35K FollowingDirector, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.
2K Followers 438 FollowingAssoc Prof, Physician-scientist researching cures for AML & MDS. Addressing health disparities in cancer care. #shastrilab Tweets my own #leusm #mds
2K Followers 1K FollowingAssociate Professor Hematologic Malignancies & Cellular Therapeutics @KUMedCenter. Alumni @uwsmph @CookCountyIMR. All views are my own
1K Followers 520 Followingpronounced like "aaron a" | bioengineering, ml and medicine | Church lab @harvard, AAV @dyno_tx, proteins @Caltech , medicine @uvmvermont
11K Followers 8K FollowingMPharm | CEO @eneksia | Scientific communicator on longevity, well-being & healthy living | Passionate about life & good people.
10K Followers 410 FollowingLeukemia professor & chair @MDAndersonNews. Unable to provide medical advice here; contact the clinic, or call 877-632-6789 for an appointment. Views are mine.
6K Followers 347 FollowingLearn to invest in biotech like the professionals from a former biotech executive and investment banker. For education purposes only. Course on Thinkific
7K Followers 329 FollowingFather. Cardiac Electrophysiologist. Personalizing heart disease using imaging and Digital Health. Tulane University. Tweets are my own.
9K Followers 733 FollowingProfessor, Dept of Leukemia, MD Anderson Cancer Center | Director, CAR-T Leukemia Program | #CLL #ALL #TcellRx | via @aiims_newdelhi | Tweets: my own opinions
71K Followers 108 Following47 yrs before the mast. Invented FierceBiotech, founded Endpoints News w/ 243,000 subs. Devoting time to the big showdown with Merkel cell carcinoma . We'll see
53K Followers 736 FollowingEarly stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
16K Followers 48 FollowingScience and Innovation. Special interest in BioTech, Pharma, Gene Editing and CRISPR 🧬. Sharing my thoughts & 📊 on the Global Economy & Financial Markets. 📈
4K Followers 685 FollowingAssociate Professor, UM Sylvester Comprehensive Cancer Center. Physician scientist studying the role of nuclear export and kinases in hematologic cancers.
7K Followers 357 FollowingDirector of Cardiac Electrophysiology at @NorthwesternMed and Bluhm Cardiovascular Institute @NMCardioVasc, Editor-in-Chief of @JCardioEP and @EPLabDigest
4K Followers 264 FollowingDirector of the @GACancerCenter. Leukemia specialist. Focus on CML, AML, MPN, MDS, new drug discovery. Aspiring runner. Opinions are my own. @icmlf